Luliconazole
CAS 187164-19-8
In Stock
Luliconazole
Cat. No. STUB-API-LULICONAZOLECAS 187164-19-8In Stock
Technical Data
Cat. No.STUB-API-LULICONAZOLE
CAS187164-19-8
Mol. FormulaC14H9Cl2N3S2
Mol. Weight354.287 g/mol
IUPAC(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile
SMILESC1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl
InChIInChI=1S/C14H9Cl2N3S2/c15-9-1-2-10(11(16)5-9)13-7-20-14(21-13)12(6-17)19-4-3-18-8-19/h1-5,8,13H,7H2/b14-12+/t13-/m0/s1
InChI KeyYTAOBBFIOAEMLL-REQDGWNSSA-N
Purity—
Description
Overview
Luliconazole is a topical antifungal agent that acts by unknown mechanisms but is postulated to involve altering the synthesis of fungi cell membranes. It was approved by the FDA (USA) in November 2013 and is marketed under the brand name Luzu. Luliconazole is also approved in Japan
Anant Labs manufacture and furnish high quality Luliconazole impurities for global markets. Our Luliconazole EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Luliconazole187164-19-8LuliconNND-502LuzuPR-2699NND502luliconazol(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrileDTXSID3048607
